A new phase 3 study comparing mono and duo therapies may yield greater guidance and treatment options for children with pulmonary arterial hypertension (PAH). PAH is a rare condition in children, but ...

Please provide your email address to receive an email when new articles are posted on . The Kids MoD PAH Trial is recruiting pediatric patients with newly diagnosed PAH. Sildenafil plus bosentan vs.

Add Yahoo as a preferred source to see more of our stories on Google. At the 2025 American Heart Association (AHA) Scientific Sessions in New Orleans, researchers shared pooled results from three ...

Clinical trial designed to evaluate ROC-101 in combination with standard of care therapies including sotatercept NATICK, Mass. /PRNewswire/ -- AllRock Bio, Inc., a ...

GOTHENBURG, Sweden, March 31, 2026 /PRNewswire/ -- Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare ...

Guest writer Genesis “Gigi” Gonzalez says that, while living with PH, there are moments when she wants to ask, "Why did this ...

The FDA has approved YUTREPIA™ (treprostinil) inhalation powder, developed by Liquidia Corporation, as a treatment option for adults with pulmonary arterial hypertension (PAH) and pulmonary ...

The ZENITH trial demonstrated sotatercept's efficacy in reducing severe outcomes in high-risk PAH, leading to early trial termination for efficacy. Oral semaglutide in the SOUL trial reduced major ...

United Therapeutics surged more than 12% in pre-market trading on March 30 after positive TETON-1 trial data triggered price ...